Takahiro Kamio
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 4
- Oncology top 5%
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 4
-
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Treatments and Mutations 3
- Advanced Breast Cancer Therapies 2
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Hisato KawakamiKensei YamaguchiHiroshi YabusakiKaku SaitoNaotoshi SugimotoHyun Cheol ChungKohei ShitaraDaisuke Sakai
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (7 papers)Cancer Research (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Takahiro Kamio
19 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Gastroenterology 163
- Oncology 775
- Pulmonary and Respiratory Medicine 600
- Radiology, Nuclear Medicine and Imaging 313
- Cancer Research 82
Countries citing papers authored by Takahiro Kamio
This map shows the geographic impact of Takahiro Kamio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Kamio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Kamio more than expected).
Fields of papers citing papers by Takahiro Kamio
This network shows the impact of papers produced by Takahiro Kamio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Kamio. The network helps show where Takahiro Kamio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takahiro Kamio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 43 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 76 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 2 | |
| 12 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancerbreakdown → | 2020 | 802 |
| 13 | 2020 | 3 | |
| 14 | 2020 | 38 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 5 | |
| 17 | 2018 | 3 | |
| 18 | 2007 | 48 | |
| 19 | A Value Profiler for Assisting Object-Oriented Program Specialization | 2004 | 2 |
| 20 | 1992 | 9 |
About Takahiro Kamio
Takahiro Kamio is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (13 papers), HER2/EGFR in Cancer Research (12 papers), Colorectal Cancer Treatments and Studies (5 papers), Peptidase Inhibition and Analysis (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Gastroenterology (163 citations), Oncology (775 citations) and Pulmonary and Respiratory Medicine (600 citations). Takahiro Kamio has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Hisato Kawakami, Kensei Yamaguchi, Hiroshi Yabusaki, Kaku Saito, Naotoshi Sugimoto, Hyun Cheol Chung, Kohei Shitara, Daisuke Sakai, Satoru Iwasa and Masahiro Sugihara. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.